1. Home
  2. POET vs EMBC Comparison

POET vs EMBC Comparison

Compare POET & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POET Technologies Inc.

POET

POET Technologies Inc.

HOLD

Current Price

$6.83

Market Cap

843.0M

Sector

Technology

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$9.63

Market Cap

602.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POET
EMBC
Founded
1972
1924
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
843.0M
602.3M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
POET
EMBC
Price
$6.83
$9.63
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
5.5M
906.8K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
6.18%
EPS Growth
N/A
20.90
EPS
N/A
0.74
Revenue
N/A
N/A
Revenue This Year
$2,939.08
$1.17
Revenue Next Year
$710.17
N/A
P/E Ratio
N/A
$13.18
Revenue Growth
N/A
N/A
52 Week Low
$3.10
$9.20
52 Week High
$9.41
$15.55

Technical Indicators

Market Signals
Indicator
POET
EMBC
Relative Strength Index (RSI) 58.24 33.73
Support Level $5.05 $9.45
Resistance Level $7.66 $10.88
Average True Range (ATR) 0.45 0.35
MACD 0.18 -0.02
Stochastic Oscillator 76.00 2.67

Price Performance

Historical Comparison
POET
EMBC

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: